Calcitriol/calcifediol ratio: An indicator of vitamin D hydroxylation efficiency?

BBA Clinical

Volumn 3, Issue , 2015, Pages 251-256

  Pasquali, Marzia ^a   Tartaglione, Lida ^a   Rotondi, Silverio ^a   Muci, Maria Luisa ^a   Mandanici, Giusi ^a   Farcomeni, Alessio ^b   Marangella, Martino ^c   Mazzaferro, Sandro ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c MAURIZIANO HOSPITAL   (Italy)

Author keywords

Calcifediol; Calcitriol; Chronic renal failure; Renal transplantation; Vitamin D; Vitamin D hydroxylation

Indexed keywords

CALCIFEDIOL; CALCITRIOL; CALCIUM; CREATININE; PARATHYROID HORMONE; PHOSPHATE;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CALCITRIOL CALCIFEDIOL RATIO; CALCIUM BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CREATININE BLOOD LEVEL; FEMALE; GLOMERULUS FILTRATION RATE; HEMODIALYSIS; HUMAN; HYDROXYLATION; KIDNEY GRAFT; MAJOR CLINICAL STUDY; MALE; NEPHROLITHIASIS; PARAMETERS; PHOSPHATE BLOOD LEVEL; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; PROTEINURIA; RADIOIMMUNOASSAY; VITAMIN D HYDROXYLATION;

EID: 84925780905     PISSN: 22146474     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbacli.2015.03.004     Document Type: Article

References (28)

1. Jones G., Prosser D.E. The Activating Enzymes of Vitamin D Metabolism (25- and 1 alpha-Hydroxylases). Vitamin D 2011, 23-42. Academic Press. 3rd ed. D. Feldman, J.W. Pike, S.J. Adams (Eds.).
2. Prosser D.E., Jones G. Enzymes involved in the activation and inactivation of vitamin D. Trends Biochem. Sci. 2004 December, 29(12):664-673.
3. Takeyama K., Kato S. The vitamin D3 1alpha-hydroxylase gene and its regulation by active vitamin D3. Biosci. Biotechnol. Biochem. 2011, 75(2):208-213.
4. St-Arnaud R. CYP24A1: Structure, Function, and Physiological Role. Vitamin D 2011, 43-56. Academic Press. 3rd ed. D. Feldman, J.W. Pike, S.J. Adams (Eds.).
5. Schuster I., Egger H., Nussbaumer P., Kroemer R.T. Inhibitors of vitamin D hydroxylases: structure-activity relationships. J. Cell. Biochem. 2003 February 1, 88(2):372-380.
6. Weinstein M.B. Drug and Hormone Effects on Vitamin D Metabolism. Vitamin D 2011, 43-56. Academic Press. Third ed. D. Feldman, J.W. Pike, S.J. Adams (Eds.).
7. Clemens T.L., Fraher L.J., Sandler L.M., O'Rioedan J.L. Demonstration of circulating 1,24,25-trihydroxyvitamin D3 in man by radioimmunoassay. Clin. Endocrinol. 1982 Apr, 16(4):337-343.
8. Holick M.F. Vitamin D for health and in chronic kidney disease. Semin. Dial. 2005 July, 18(4):266-275.
9. Dusso A.S., Gonzalez E.A., Martin K.J. Vitamin D. Best Pract. Res. Clin. Endocrinol. Metab. 2011 Aug, 25(4):647-655.
10. Adams J.S., Hewison M. Update in vitamin D. J. Clin. Endocrinol. Metab. 2010 February, 95(2):471-478.
11. Levin A., Bakris G.L., Molitch M., Smulders M., Tian J., Williams L.A., et al. Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int. 2007 January, 71(1):31-38.
12. Quarles L.D. Role of FGF23 in vitamin D and phosphate metabolism: implications in chronic kidney disease. Exp. Cell Res. 2012 May, 318(9):1040-1048.
13. Kawata T., Imanishi Y., Kobayashi K., Miki T., Arnold A., Inaba M., et al. Parathyroid hormone regulates fibroblast growth factor-23 in a mouse model of primary hyperparathyroidism. J. Am. Soc. Nephrol. 2007 October, 18(10):2683-2688.
14. Kobayashi K., Imanishi Y., Miyauchi A., Onoda N., Kawata T., Tahara H., et al. Regulation of plasma fibroblast growth factor 23 by calcium in primary hyperparathyroidism. Eur. J. Endocrinol. 2006 January, 154(1):93-99.
15. Witteveen J.E., van Lierop A.H., Papapoulos S.E., Hamdy N.A. Increased circulating levels of FGF23: an adaptive response in primary hyperparathyroidism?. Eur. J. Endocrinol. 2012 January, 166(1):55-60.
16. Moosgaard B., Vestergaard P., Heickendorff L., Mosekilde L. Plasma 1,25-dihydroxyvitamin D levels in primary hyperparathyroidism depend on sex, body mass index, plasma phosphate and renal function. Clin. Endocrinol.(Oxf) 2007 January, 66(1):35-42.
17. Aygencel G., Turkoglu M., Tuncel A.F., Candir B.A., Bildaci Y.D., Pasaoglu H. Is vitamin D insufficiency associated with mortality of critically ill patients?. Crit. Care Res. Pract. 2013, 2013:856747.
18. Villasenor A., Ballard-Barbash R., Ambs A., Bernstein L., Baumgartner K., Baumgartner R., et al. Associations of serum 25-hydroxyvitamin D with overall and breast cancer-specific mortality in a multiethnic cohort of breast cancer survivors. Cancer Causes Control 2013 April, 24(4):759-767.
19. Dobnig H., Pilz S., Scharnagl H., Renner W., Seelhorst U., Wellnitz B., et al. Independent association of low serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality. Arch. Intern. Med. 2008 June 23, 168(12):1340-1349.
20. Wu P.W., Rhew E.Y., Dyer A.R., Dunlop D.D., Langman C.B., Price H., et al. 25-hydroxyvitamin D and cardiovascular risk factors in women with systemic lupus erythematosus. Arthritis Rheum. 2009 October 15, 61(10):1387-1395.
21. Tomson J., Emberson J., Hill M., Gordon A., Armitage J., Shipley M., et al. Vitamin D and risk of death from vascular and non-vascular causes in the Whitehall study and meta-analyses of 12,000 deaths. Eur. Heart J. 2013 May, 34(18):1365-1374.
22. Brondum-Jacobsen P., Benn M., Jensen G.B., Nordestgaard B.G. 25-hydroxyvitamin D levels and risk of ischemic heart disease, myocardial infarction, and early death: population-based study and meta-analyses of 18 and 17 studies. Arterioscler. Thromb. Vasc. Biol. 2012 November, 32(11):2794-2802.
23. Pilz S., Dobnig H., Nijpels G., Heine R.J., Stehouwer C.D., Snijder M.B., et al. Vitamin D and mortality in older men and women. Clin. Endocrinol. (Oxf) 2009 November, 71(5):666-672.
24. Melamed M.L., Michos E.D., Post W., Astor B. 25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch. Intern. Med. 2008 August 11, 168(15):1629-1637.
25. Wacker M., Holick M.F. Sunlight and Vitamin D: a global perspective for health. Dermatoendocrinol 2013 Jan, 5(1):51-108.
26. Armas L.A., Zena M., Lund R., Heaney R.P. Calcium absorption response to cholecalciferol supplementation in hemodialysis. Clin. J. Am. Soc. Nephrol. 2013 June, 8(6):1003-1008.
27. Hewitt N.A., O'Connor A.A., O'Shaughnessy D.V., Elder G.J. Effects of cholecalciferol on functional, biochemical, vascular, and quality of life outcomes in hemodialysis patients. Clin. J. Am. Soc. Nephrol. 2013 July, 8(7):1143-1149.
28. Courbebaisse M., Thervet E., Souberbielle J.C., Zuber J., Eladari D., Martinez F., et al. Effects of vitamin D supplementation on the calcium-phosphate balance in renal transplant patients. Kidney Int. 2009 March, 75(6):646-651.